Answers are grounded in this paper and cite their sources.
A four-year follow-up observes favorable response to immunosuppressive treatment in a rare vasculitis case.
Introduction. Eosinophilic granulomatosis with polyangiitis is a rare antineutrophil cytoplasmic antibody- associated small- to medium-vessel necrotizing vasculitis characterized by asthma, eosinophilia, and heterogeneous multisystem involvement. Diagnosis is based on a combination of clinical, laboratory, and histopathological findings, in accordance with current guideline-recommended criteria. Treatment strategies are stratified according to disease severity, with systemic glucocorticoids as first-line therapy and additional immunosuppressive agents reserved for relapsing or refractory disease. Case Report. We report the case of a 44-year-old woman with a history of asthma and chronic sinusitis who presented with rapidly progressive leg pain, paresthesias, cutaneous purpura, and constitutional symptoms. Laboratory investigations revealed marked leukocytosis with severe eosinophilia, anemia, elevated inflammatory markers, and strongly positive anti-myeloperoxidase antibodies. Electromyography demonstrated chronic sensorimotor polyneuropathy, while muscle biopsy confirmed acute necrotizing vasculitis. Cardiac involvement was excluded, and renal function and urinalysis remained normal. Given the severity of clinical manifestations, induction therapy with high-dose glucocorticoids and methotrexate was initiated, followed by a structured tapering regimen during outpatient follow-up. Over a four-year follow-up period, the patient achieved rapid clinical improvement, normalization of eosinophil counts, resolution of neuropathic and cutaneous manifestations, and sustained antineutrophil cytoplasmic antibodies negativity. Complete remission was maintained after discontinuation of both glucocorticoids and methotrexate, without evidence of relapse. Conclusion. This case illustrated that eosinophilic granulomatosis with polyangiitis without adverse prognostic factors can respond favorably to timely diagnosis and appropriately tailored immunosuppressive therapy. Early initiation of glucocorticoids combined with methotrexate, supported by structured monitoring and guided tapering, resulted in complete and sustained remission with full recovery of neurologic and cutaneous involvement. Durable remission following treatment withdrawal highlights the potential for long-term disease control in selected patients.
No takes yet. Share an insight, caveat, or question.
Sajinovic et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: